INSYS THERAPUETICS INC | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for INSYS THERAPUETICS INC

Sort by

Viewing results 1‒15 of 15

US opioid epidemic
Opioid executive admits to ‘no morals’ ahead of prison term
...But the vast majority of doctors Insys targeted were not oncologists....
January 23, 2020
FT News Briefing podcast12 min listen
The inside story of a disgraced drugmaker
...Read the story at ft.com/insys....
June 19, 2020
FT Live
US Pharma and Biotech Summit
Strategies for innovation, pricing and access
Thursday, 16 MayNew York, NY, USA
FT Magazine
Opioids, bribery and Wall Street: the inside story of a disgraced drugmaker
...Hannah Kuchler, Shaunagh Connaire, Nick Verbitsky, Annie Wong, Rebecca Blandon and Tom Jennings This story is part of a collaboration with the PBS series FRONTLINE, which includes the documentary ‘Opioids, Inc...
June 19, 2020
FirstFT
FirstFT: Today’s top stories
...(FT) Opioids Inc The pharmaceutical company Insys has come a long way from its former status as a Wall Street darling....
June 19, 2020
Insys Therapeutics Inc
Opioid maker Insys files for Chapter 11 bankruptcy
...Insys aims to complete the asset sales and address its liabilities within 90 days. Insys shares have fallen more than 97 per cent since their peak in 2015....
June 10, 2019
News in-depthUS opioid epidemic
Insys bankruptcy sets up opioid test case as US states seek cash
...Judge Kevin Gross, who is overseeing the Insys bankruptcy case, will have to decide whether those cases are just about pursuing money — as Insys argues — or about ensuring the company obeys the rules....
June 11, 2019
FT Live
Global Pharma and Biotech Summit
Driving life sciences innovation in a disrupted world
Tuesday, 5 NovemberIn-Person & Online Conference
Insys Therapeutics Inc
Opioid maker Insys agrees to pay $225m to settle US criminal cases
...In total, eight Insys executives have been prosecuted....
June 6, 2019
Insys Therapeutics Inc
Insys founder convicted in opioid bribery case
...Insys said Mr Kapoor’s shares were being managed by an independent trust and would be until they are disposed. Mr Kapoor owns 63.2 per cent of Insys shares, worth about $194.6m....
May 2, 2019
News in-depthUS opioid epidemic
Drugmakers braced for opioid crisis reckoning
...Insys, the maker of Subsys, a spray based on the very powerful opioid fentanyl, settled a case for $225m last month....
July 12, 2019
Johnson & Johnson Co Inc
Johnson & Johnson ordered to pay $572m in opioid trial
...Oklahoma’s victory may embolden other states to pursue J&J, which has deeper pockets than opioid makers like Purdue Pharma, which has said it is considering filing for bankruptcy, and Insys, which has already...
August 26, 2019
Johnson & Johnson Co Inc
Johnson & Johnson faces court judgment over opioids crisis
...While Purdue Pharma is considering bankruptcy, and fellow opioid maker Insys has already filed for Chapter 11, J&J’s much deeper pockets make it an attractive target for legal action....
August 25, 2019
Drugs research
What next for Alzheimer’s research after latest drug failure?
...Biotech companies are taking a variety of approaches, with Bay Area start-up Denali Therapuetics exploring anti-inflammation strategies and Alector targeting the brain’s immune system....
March 22, 2019
LexRecreational drugs
Cannabis ETFs: joint venture Premium content
...One is Insys Therapeutics, a US biotech that generates revenues from opioids but spends a fifth of its research budget on cannabinoid drugs....
March 31, 2017
Dan McCrum
Insys Therapeutics vs Roddy Boyd
...Here’s one to watch from the world of speculative US healthcare: Insys Pharmaceuticals....
July 16, 2015
Fund management
Cannabis companies: puffed up
...Nasdaq-listed Insys Therapeutics, whose drugs include a synthetic cannabidiol formulation, trades at 22 times forward earnings....
March 20, 2015
FT Live
Future of Asset Management Europe
New fund firm models for Europe's resurgence
Tuesday, 12 NovemberLondon, UK

Previous pagePage 1 of 1Next page